Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'streptogramin' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 186 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bonfiglio, G; Furneri, PM
      Novel streptogramin antibiotics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Voelker, F; Altaba, S
      Nitrogen source governs the patterns of growth and pristinamycin production in 'Streptomyces pristinaespiralis'

      MICROBIOLOGY-SGM
    3. Douthwaite, S
      Structure-activity relationships of ketolides vs. macrolides

      CLINICAL MICROBIOLOGY AND INFECTION
    4. Leclercq, R
      Safeguarding future antimicrobial options: strategies to minimize resistance

      CLINICAL MICROBIOLOGY AND INFECTION
    5. Schwarz, S; Chaslus-Dancla, E
      Use of antimicrobials in veterinary medicine and mechanisms of resistance

      VETERINARY RESEARCH
    6. Werckenthin, C; Cardoso, M; Martel, JL; Schwarz, S
      Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius

      VETERINARY RESEARCH
    7. Fluit, AC; Visser, MR; Schmitz, FJ
      Molecular detection of antimicrobial resistance

      CLINICAL MICROBIOLOGY REVIEWS
    8. Boerlin, P; Burnens, AP; Frey, J; Kuhnert, P; Nicolet, J
      Molecular epidemiology and genetic linkage of macrolide and aminoglycosideresistance in Staphylococcus intermedius of canine origin

      VETERINARY MICROBIOLOGY
    9. Linden, PK; Bompart, F; Gray, S; Talbot, GH
      Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: Correlation with available liver biopsy results

      PHARMACOTHERAPY
    10. Grau, S; Alvarez-Lerma, F; Marin, M; Gimeno, JL
      Problems and current solutions for the treatment of infections caused by gram-positive microorganisms

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    11. Allington, DR; Rivey, MP
      Quinupristin/dalfopristin: A therapeutic review

      CLINICAL THERAPEUTICS
    12. Lakkis, C; Fleiszig, SMJ
      Resistance of Pseudomonas aeruginosa isolates to hydrogel contact lens disinfection correlates with cytotoxic activity

      JOURNAL OF CLINICAL MICROBIOLOGY
    13. Werner, G; Cuny, C; Schmitz, FJ; Witte, W
      Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides

      JOURNAL OF CLINICAL MICROBIOLOGY
    14. Fuchs, PC; Barry, AL; Brown, SD
      Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    15. Aarestrup, FM; Seyfarth, AM; Emborg, HD; Pedersen, K; Hendriksen, RS; Bager, F
      Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    16. Zarrouk, V; Bozdogan, B; Leclercq, R; Garry, L; Feger, C; Carbon, C; Fantin, B
      Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    17. Hillier, MC; Price, AT; Meyers, AI
      Studies on the total synthesis of disorazole C-1. An advanced macrocycle intermediate

      JOURNAL OF ORGANIC CHEMISTRY
    18. Ma, ZK; Clark, RF; Brazzale, A; Wang, SY; Rupp, MJ; Li, LP; Griesgraber, G; Zhang, SM; Yong, H; Phan, LT; Nemoto, PA; Chu, DTW; Plattner, JJ; Zhang, XL; Zhong, P; Cao, ZS; Nilius, AM; Shortridge, VD; Flamm, R; Mitten, M; Meulbroek, J; Ewing, P; Alder, J; Or, YS
      Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens

      JOURNAL OF MEDICINAL CHEMISTRY
    19. Ling, TKW; Fung, KSC; Cheng, AFB
      In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid)

      CHEMOTHERAPY
    20. Frey, AD; Rimann, M; Bailey, JE; Kallio, PT; Thompson, CJ; Fussenegger, M
      Novel pristinamycin-responsive expression systems for plant cells

      BIOTECHNOLOGY AND BIOENGINEERING
    21. Wu, YJ
      Highlights of semi-synthetic developments from erythromycin A

      CURRENT PHARMACEUTICAL DESIGN
    22. Nichols, RL; Graham, DR; Barriere, SL; Rodgers, A; Wilson, SE; Zervos, M; Dunn, DL; Kreter, B
      Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections - Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (Reprinted from The Journal of Antimicrobial Chemotherapy, vol 44, pg 263-273, 1999)

      FORMULARY
    23. Werner, G; Klare, I; Heier, H; Hinz, KH; Bohme, G; Wendt, M; Witte, W
      Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    24. Witte, W
      Selective pressure by antibiotic use in livestock

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    25. Marshall, SA; Kugler, KC; Jones, RN
      Evaluation of quinupristin/dalfopristin (Synercid (R)) and RPR 106 972 stability in susceptibility testing media

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    26. Zuckerman, JM
      The newer macrolides: Azithromycin and clarithromycin

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    27. Nawaz, MS; Khan, SA; Khan, AA; Khambaty, FM; Cerniglia, CE
      Comparative molecular analysis of erythromycin-resistance determinants in staphylococcal isolates of poultry and human origin

      MOLECULAR AND CELLULAR PROBES
    28. Dowzicky, M; Talbot, GH; Feger, C; Prokocimer, P; Etienne, J; Leclercq, R
      Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid (R)) during a worldwide clinical program

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    29. Aarestrup, FM; Agerso, Y; Ahrens, P; Jorgensen, JCO; Madsen, M; Jensen, LB
      Antimicrobial susceptibility and presence of resistance genes in staphylococci from poultry

      VETERINARY MICROBIOLOGY
    30. Lozniewski, A; Lion, C; Mory, F; Weber, M
      Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae

      PATHOLOGIE BIOLOGIE
    31. Fines, M; Leclercq, R
      Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors

      Journal of antimicrobial chemotherapy
    32. Delgado, G; Neuhauser, MM; Bearden, DT; Danziger, LH
      Quinupristin-dalfopristin: An overview

      PHARMACOTHERAPY
    33. Butaye, P; Van Damme, K; Devriese, LA; Van Damme, L; Baele, M; Lauwers, S; Haesebrouck, F
      In vitro susceptibility of Enterococcus faecium isolated from food to growth-promoting and therapeutic antibiotics

      INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
    34. Yan, JJ; Wu, HM; Huang, AH; Fu, HM; Lee, CT; Wuz, JJ
      Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan

      JOURNAL OF CLINICAL MICROBIOLOGY
    35. Waites, K; Johnson, C; Gray, B; Edwards, K; Crain, M; Benjamin, W
      Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children

      JOURNAL OF CLINICAL MICROBIOLOGY
    36. Vouillamoz, J; Entenza, JM; Feger, C; Glauser, MP; Moreillon, P
      Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistantto macrolide-lincosamide-streptogramin B antibiotics

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Zarrouk, V; Bozdogan, S; Leclercq, R; Garry, L; Carbon, C; Fantin, B
      Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    38. Martineau, F; Picard, FJ; Lansac, N; Menard, C; Roy, PH; Ouellette, M; Bergeron, MG
      Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    39. Soltani, M; Beighton, D; Philpott-Howard, J; Woodford, N
      Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in westernEurope

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    40. Tait-Kamradt, A; Davies, T; Appelbaum, PC; Depardieu, F; Courvalin, P; Petitpas, J; Wondrack, L; Walker, A; Jacobs, MR; Sutcliffe, J
      Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    41. Fuchs, PC; Barry, AL; Brown, SD
      Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: Clindamycin susceptibility as a surrogate indicator

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    42. Marcantoni, E; Massaccesi, M; Petrini, M; Bartoli, G; Bellucci, MC; Bosco, M; Sambri, L
      A novel route to the vinyl sulfide nine-membered macrocycle moiety of Griseoviridin

      JOURNAL OF ORGANIC CHEMISTRY
    43. Noguchi, N; Takada, K; Katayama, J; Emura, A; Sasatsu, M
      Regulation of transcription of the mph(A) gene for macrolide 2 '-phosphotransferase I in Escherichia coli: Characterization of the regulatory gene mphR(A)

      JOURNAL OF BACTERIOLOGY
    44. Khan, SA; Nawaz, MS; Khan, AA; Steele, RS; Cerniglia, CE
      Characterization of erythromycin-resistant methylase genes from multiple antibiotic resistant Staphylococcus spp isolated from milk samples of lactating cows

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    45. Chu, DTW
      Recent developments in macrolides and ketolides

      CURRENT OPINION IN MICROBIOLOGY
    46. Porse, BT; Kirillov, SV; Awayez, MJ; Garrett, RA
      UV-induced modifications in the peptidyl transferase loop of 23S rRNA dependent on binding of the streptogramin B antibiotic, pristinamycin IA

      RNA-A PUBLICATION OF THE RNA SOCIETY
    47. Schwarz, S; Noble, WC
      Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice

      VETERINARY DERMATOLOGY
    48. Amsden, GW
      Pharmacological considerations in the emergence of resistance

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    49. Khan, SA; Nawaz, MS; Khan, AA; Cerniglia, CE
      Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR

      MOLECULAR AND CELLULAR PROBES
    50. Chang, SC; Fang, CT; Hsueh, PR; Luh, KT; Hsieh, WC
      In vitro activity of quinupristin/dalfopristin against clinical isolates of common Gram-positive bacteria in Taiwan

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    51. Vasselle, B; Gousset, G; Bounine, JP
      Development and validation of a high-performance liquid chromatographic stability-indicating method for the analysis of Synercid (R) in quality control, stability and compatibility studies

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    52. Matsuoka, M; Janosi, L; Endou, K; Nakajima, Y
      Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter

      FEMS MICROBIOLOGY LETTERS
    53. White, PA; Stokes, HW; Bunny, KL; Hall, RM
      Characterisation of a chloramphenicol acetyltransferase determinant found in the chromosome of Pseudomonas aeruginosa

      FEMS MICROBIOLOGY LETTERS
    54. Jensen, LB; Frimodt-Moller, N; Aarestrup, FM
      Presence of erm gene classes in Gram-positive bacteria of animal and humanorigin in Denmark

      FEMS MICROBIOLOGY LETTERS
    55. Tsakris, A; Alexiou-Daniel, S; Souliou, E; Antoniadis, A
      In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems

      Journal of antimicrobial chemotherapy
    56. Nichols, RL; Graham, DR; Barriere, SL; Rodgers, A; Wilson, SE; Zervos, M; Dunn, DL; Kreter, B
      Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

      Journal of antimicrobial chemotherapy
    57. Nishijima, T; Saito, Y; Aoki, A; Toriya, M; Toyonaga, Y; Fujii, R
      Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics

      Journal of antimicrobial chemotherapy
    58. Thal, LA; Zervos, MJ
      Occurrence and epidemiology of resistance to virginiamycin and streptogramins

      Journal of antimicrobial chemotherapy
    59. Chung, WSO; Werckenthin, C; Schwarz, S; Roberts, MC
      Host range of the ermF rRNA methylase gene in bacteria of human and animalorigin

      Journal of antimicrobial chemotherapy
    60. Chu, DTW
      Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance

      MEDICINAL RESEARCH REVIEWS
    61. Schlegel, L; Sissia, G; Fremaux, A; Geslin, P
      Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    62. Werckenthin, C; Schwarz, S; Westh, H
      Structural alterations in the translational attenuator of constitutively expressed ermC genes

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    63. Matsumura, SO; Louie, L; Louie, M; Simor, AE
      Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    64. Zarantonelli, L; Borthagaray, G; Lee, EH; Shafer, WM
      Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrRmutations

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    65. Greko, C
      Antibiotics as growth promoters

      ACTA VETERINARIA SCANDINAVICA
    66. Nawaz, MS; Khan, AA; Khan, SA; Paine, DD; Pothuluri, JV; Cerniglia, CE
      Biochemical and molecular characterization of erythromycin-resistant avianStaphylococcus spp. isolated from chickens

      POULTRY SCIENCE
    67. Porse, BT; Garrett, RA
      Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23S rRNA and the synergism of their inhibitory mechanisms

      JOURNAL OF MOLECULAR BIOLOGY
    68. BARRIERE JC; BERTHAUD N; BEYER D; DUTKAMALEN S; PARIS JM; DESNOTTES JF
      RECENT DEVELOPMENTS IN STREPTOGRAMIN RESEARCH

      Current pharmaceutical design
    69. WEISBLUM B
      MACROLIDE RESISTANCE

      DRUG RESISTANCE UPDATES
    70. Lomaestro, BM; Briceland, LL
      Streptogramins and their potential role in geriatric medicine

      DRUGS & AGING
    71. CUPOABBOTT J; HOLTOM P; RHO JP
      FOCUS ON QUINUPRISTIN DALFOPRISTIN - AN INVESTIGATIONAL STREPTOGRAMINANTIBIOTIC FOR THE TREATMENT OF MULTIDRUG-RESISTANT GRAM-POSITIVE INFECTIONS/

      Formulary (Cleveland, Ohio)
    72. CORNAGLIA G; LIGOZZI M; MAZZARIOL A; MASALA L; LOCASCIO G; OREFICI G; FONTANA R
      RESISTANCE OF STREPTOCOCCUS-PYOGENES TO ERYTHROMYCIN AND RELATED ANTIBIOTICS IN ITALY

      Clinical infectious diseases
    73. RAAD I; ALRAHWAN A; ROLSTON K
      STAPHYLOCOCCUS-EPIDERMIDIS - EMERGING RESISTANCE AND NEED FOR ALTERNATIVE AGENTS

      Clinical infectious diseases
    74. Brooks, AK; Zervos, MJ
      New antimicrobial agents for Gram-positive infections

      CURRENT OPINION IN INFECTIOUS DISEASES
    75. BHASIN N; ALBUS A; MICHON F; LIVOLSI PJ; PARK JS; LEE JC
      IDENTIFICATION OF A GENE ESSENTIAL FOR O-ACETYLATION OF THE STAPHYLOCOCCUS-AUREUS TYPE-5 CAPSULAR POLYSACCHARIDE

      Molecular microbiology
    76. REINERT RR; KRESKEN M; MECHERY V; LEMPERLE R; LUTTICKEN R
      IN-VITRO ACTIVITY OF QUINUPRISTIN DALFOPRISTIN AGAINST ERYTHROMYCIN-SUSCEPTIBLE AND ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE/

      European journal of clinical microbiology & infectious diseases
    77. FUCHS P; BARRY A; BROWN S
      PROVISIONAL QUALITY-CONTROL PARAMETERS AND INTERPRETIVE CRITERIA FOR TESTING SUSCEPTIBILITY OF STREPTOCOCCUS-PNEUMONIAE AND HAEMOPHILUS-INFLUENZAE TO QUINUPRISTIN DALFOPRISTIN (RP59500)/

      European journal of clinical microbiology & infectious diseases
    78. MOLLER FM; BAGER F; JENSEN NE; MADSEN M; MEYLING A; WEGENER HC
      SURVEILLANCE OF ANTIMICROBIAL RESISTANCE IN BACTERIA ISOLATED FROM FOOD ANIMALS TO ANTIMICROBIAL GROWTH PROMOTERS AND RELATED THERAPEUTIC AGENTS IN DENMARK

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    79. MESSICK CR; WOODWARD J; PENDLAND SL
      IN-VITRO ACTIVITY OF RPR-106972 ALONE AND IN COMBINATION WITH VANCOMYCIN, AMPICILLIN, AND GENTAMICIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCI

      Diagnostic microbiology and infectious disease
    80. HAMMERUM AM; JENSEN LB; AARESTRUP FM
      DETECTION OF THE SATA GENE AND TRANSFERABILITY OF VIRGINIAMYCIN RESISTANCE IN ENTEROCOCCUS-FAECIUM FROM FOOD-ANIMALS

      FEMS microbiology letters
    81. SOMKUTI GA; SOLAIMAN DKY; STEINBERG DH
      MOLECULAR CHARACTERIZATION OF THE ERYTHROMYCIN RESISTANCE PLASMID PPV142 FROM STAPHYLOCOCCUS SIMULANS

      FEMS microbiology letters
    82. Barry, AL; Fuchs, PC; Brown, SD
      Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres

      Journal of antimicrobial chemotherapy
    83. SAMBATAKOU H; GIAMARELLOSBOURBOULIS EJ; GRECKA P; CHRYSSOULI Z; GIAMARELLOU H
      IN-VITRO ACTIVITY AND KILLING EFFECT OF QUINUPRISTIN DALFOPRISTIN (RP59500) ON NOSOCOMIAL STAPHYLOCOCCUS-AUREUS AND INTERACTIONS WITH RIFAMPICIN AND CIPROFLOXACIN AGAINST METHICILLIN-RESISTANT ISOLATES/

      Journal of antimicrobial chemotherapy
    84. JASIR A; SCHALEN C
      SURVEY OF MACROLIDE RESISTANCE PHENOTYPES IN SWEDISH CLINICAL ISOLATES OF STREPTOCOCCUS-PYOGENES

      Journal of antimicrobial chemotherapy
    85. OH TG; LEE MJ; BAEK MC; KIM BK; CHOI EC
      RESISTANCE TO MACROLIDE LINCOSAMIDE STREPTOGRAMIN-B ANTIBIOTICS IS INDUCED BY 16-MEMBERED RING MACROLIDE ANTIBIOTICS IN ENTEROCOCCUS-FAECALIS-373

      Archives of pharmacal research
    86. MEIJER WJJ; WISMAN GBA; TERPSTRA P; THORSTED PB; THOMAS CM; HOLSAPPEL S; VENEMA G; BRON S
      ROLLING-CIRCLE PLASMIDS FROM BACILLUS-SUBTILIS - COMPLETE NUCLEOTIDE-SEQUENCES AND ANALYSES OF GENES OF PTA1015, PTA1040, PTA1050 AND PTA1060, AND COMPARISONS WITH RELATED PLASMIDS FROM GRAM-POSITIVE BACTERIA

      FEMS microbiology reviews
    87. AESCHLIMANN JR; RYBAK MJ
      PHARMACODYNAMIC ANALYSIS OF THE ACTIVITY OF QUINUPRISTIN-DALFOPRISTINAGAINST VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM WITH DIFFERING MBCSVIA TIME-KILL-CURVE AND POSTANTIBIOTIC EFFECT METHODS

      Antimicrobial agents and chemotherapy
    88. SEPPALA H; SKURNIK M; SOINI H; ROBERTS MC; HUOVINEN P
      A NOVEL ERYTHROMYCIN RESISTANCE METHYLASE GENE (ERMTR) IN STREPTOCOCCUS-PYOGENES

      Antimicrobial agents and chemotherapy
    89. NICOLA FG; MCDOUGAL LK; BIDDLE JW; TENOVER FC
      CHARACTERIZATION OF ERYTHROMYCIN-RESISTANT ISOLATES OF STAPHYLOCOCCUS-AUREUS RECOVERED IN THE UNITED-STATES FROM 1958 THROUGH 1969

      Antimicrobial agents and chemotherapy
    90. AESCHLIMANN JR; ZERVOS MJ; RYBAK MJ
      TREATMENT OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM WITH RP-59500 (QUINUPRISTIN-DALFOPRISTIN) ADMINISTERED BY INTERMITTENT OR CONTINUOUS-INFUSION, ALONE OR IN COMBINATION WITH DOXYCYCLINE, IN AN IN-VITRO PHARMACODYNAMIC INFECTION MODEL WITH SIMULATED ENDOCARDIAL VEGETATIONS

      Antimicrobial agents and chemotherapy
    91. SUH YG; JUNG JK; SUH BC; LEE YC; KIM SA
      A FORMAL SYNTHESIS OF (+)-BREFELDIN-A

      Tetrahedron letters
    92. ENTWISTLE DA; JORDAN SI; MONTGOMERY J; PATTENDEN G
      TOTAL SYNTHESIS OF OXAZOLE-BASED VIRGINIAMYCIN ANTIBIOTICS - 14,15-ANHYDROPRISTINAMYCIN IIB

      Synthesis
    93. GRIESGRABER G; KRAMER MJ; ELLIOTT RL; NILIUS AM; EWING PJ; RANEY PM; BUI MH; FLAMM RK; CHU DTW; PLATTNER JJ; OR YS
      ANHYDROLIDE MACROLIDES - 2 - SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 2,3-ANHYDRO-6-O-METHYL 11,12-CARBAZATE ERYTHROMYCIN-A ANALOGS

      Journal of medicinal chemistry
    94. SCHWARZ S; LANGE C; WERCKENTHIN C
      ANTIMICROBIAL RESISTANCE - MOLECULAR ANALYSIS OF THE MACROLIDE-LINCOSAMIDE RESISTANCE GENE REGION OF A NOVEL PLASMID FROM STAPHYLOCOCCUS-HYICUS

      Journal of Medical Microbiology
    95. OH TG; KWON AR; CHOI EC
      INDUCTION OF ERMAMR FROM A CLINICAL STRAIN OF ENTEROCOCCUS-FAECALIS BY 16-MEMBERED-RING MACROLIDE ANTIBIOTICS

      Journal of bacteriology (Print)
    96. REYZELMAN AM; VANGILS CC; HARDIN TC; VAYSER DJ; HARKLESS LB
      VANCOMYCIN-RESISTANT ENTEROCOCCI OSTEOMYELITIS IN THE FOOT - A CASE-REPORT

      Journal of the American Podiatric Medical Association
    97. BATEMAN KP; THIBAULT P; YANG KQ; WHITE RL; VINING LC
      PROBING THE SUBSTRATE-SPECIFICITY OF AN ENZYME CATALYZING INACTIVATION OF STREPTOGRAMIN-B ANTIBIOTICS USING LC-MS AND LC-MS MS/

      Journal of mass spectrometry.
    98. STAMATAKIS MK; RICHARDS JG
      INTERACTION BETWEEN QUINUPRISTIN DALFOPRISTIN AND CYCLOSPORINE/

      The Annals of pharmacotherapy
    99. LAUNAY O; CHEMLAL K; ANDRIEU V; CARBON C
      SEVERE REVERSIBLE RETICULOCYTOPENIC ANEMIA ASSOCIATED WITH QUINUPRISTIN DALFOPRISTIN RP59500 THERAPY/

      Clinical infectious diseases
    100. BARRY AL; FUCHS PC; BROWN SD
      IN-VITRO ACTIVITY OF AN ORALLY-ADMINISTERED STREPTOGRAMIN (RPR-106,972) COMPARED TO QUINUPRISTIN DALFOPRISTIN AND ERYTHROMYCIN/

      European journal of clinical microbiology & infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 10:40:32